- Home
- HQI vs SEER Comparison
HQI vs SEER Comparison
Compare HQI & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- SEER
- Stock Information
- Founded
- HQI 2002
- SEER 2017
- Country
- HQI United States
- SEER United States
- Employees
- HQI N/A
- SEER N/A
- Industry
- HQI Professional Services
- SEER Medicinal Chemicals and Botanical Products
- Sector
- HQI Consumer Discretionary
- SEER Health Care
- Exchange
- HQI Nasdaq
- SEER Nasdaq
- Market Cap
- HQI 143.3M
- SEER 125.3M
- IPO Year
- HQI N/A
- SEER 2020
- Fundamental
- Price
- HQI $9.82
- SEER $2.11
- Analyst Decision
- HQI Strong Buy
- SEER Hold
- Analyst Count
- HQI 2
- SEER 1
- Target Price
- HQI $16.00
- SEER $3.00
- AVG Volume (30 Days)
- HQI 14.9K
- SEER 134.7K
- Earning Date
- HQI 08-07-2025
- SEER 08-07-2025
- Dividend Yield
- HQI 2.49%
- SEER N/A
- EPS Growth
- HQI N/A
- SEER N/A
- EPS
- HQI 0.24
- SEER N/A
- Revenue
- HQI $33,651,000.00
- SEER $15,309,000.00
- Revenue This Year
- HQI N/A
- SEER $26.18
- Revenue Next Year
- HQI $4.99
- SEER $29.58
- P/E Ratio
- HQI $39.80
- SEER N/A
- Revenue Growth
- HQI N/A
- SEER N/A
- 52 Week Low
- HQI $9.04
- SEER $1.59
- 52 Week High
- HQI $15.75
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- HQI 48.58
- SEER 49.54
- Support Level
- HQI $10.20
- SEER $2.11
- Resistance Level
- HQI $10.41
- SEER $2.22
- Average True Range (ATR)
- HQI 0.19
- SEER 0.07
- MACD
- HQI -0.01
- SEER -0.00
- Stochastic Oscillator
- HQI 43.25
- SEER 45.90
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.